NCT02325505View on ClinicalTrials.gov

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

August 31, 2022

Conditions
Tuberous SclerosisLymphangioleiomyomatosisAngiomyolipoma
Trial Locations (3)

05303900

InCor Heart Institute, São Paulo

05403900

InCor Heart Institute, Research Center, São Paulo

InCor Heart Institute, São Paulo

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

InCor Heart Institute

OTHER